Biogen has taken up an option on a technology developed by Denali that it thinks could help improve the safety and efficacy of amyloid-targeting drugs for Alzheimer’s disease. The technology ...

The pharma industry's dogged determination to develop amyloid-targeting therapies for Alzheimer's disease is a "road to nowhere", according to the scientist behind a rival approach. Claude Wischik ...

It is the most common cause of dementia. Microglia have a central role in the clearance of amyloid-β after immunotherapy in Alzheimer’s disease. By integrating spatial transcriptomics and ...

ABSTRACT: Cardiac amyloidosis (CA) is a progressive and life-threatening manifestation of systemic amyloidosis characterized by extracellular deposition of insoluble amyloid fibrils in the myocardium.

Women and those with paternal history of Alzheimer disease have stronger association between Aβ, tau deposition than men or those with maternal history. Valentin Ourry, Ph.D., from McGill ...

Alnylam and BridgeBio are competing for people who are switching from Pfizer’s blockbuster ATTR amyloidosis drug tafamidis while all three companies are fighting for new patients. A three-way tussle ...

With nine years’ experience, Tebogo Mokwena, a current affairs writer for Briefly News, provided insights into the criminal justice system, crime statistics and high-profile cases in South Africa at ...

Elevate your nuclear cardiology knowledge with the redesigned program, Nuclear Cardiology: Basic Principles, Current Practice & Future Directions. You'll learn the latest on SPECT/PET myocardial ...

Harold Baines, MLB Hall of Famer, has a genetic condition called amyloidosis which is a rare disease characterized by a buildup of abnormal amyloid deposits in the body. As a result, he needed both a ...